The initiative of the African Pharmaceutical Technology Foundation (APTF), launched by the African Development Bank, will play a crucial role in supporting African pharmaceutical companies.
These firms will require a highly efficient technological infrastructure.
These statements by Minister of International Co-operation Rania el-Mashaat came during discussions on the joint initiative between the African Union and the African Development Bank to launch the African Pharmaceutical Technology Foundation (APTF) ahead of the annual meetings of the African Development Bank in Sharm el-Sheikh on 22-26 May.
The minister said the meetings of the African Development Bank are happening at a time when the African continent is faced with multiple challenges to all aspects of development.
The minister affirmed Egypt’s support for the partnerships and initiatives launched by the African Development Bank to stimulate innovation and develop health care efforts and the pharmaceutical industry.
The pharmaceuticals market in Egypt with worth $3 billion and is expected to grow in the medium term, thanks to government efforts to restructure the pharmaceutical industry in Egypt.
Egypt is one of the countries that dealt with Covid-19 successfully, according to the report of the World Health Organisation, as Egypt increased investment in scientific research to confront the pandemic, in addition to expanding presidential health initiatives such as 100 Million Healthy Lives and the presidential rural development initiative Decent Life.
Discussion about this post